IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Rhabdomyosarcoma
St. Jude Children's Research Hospitalmonoclonal_antibodyPhase 1Dormant
CC
42/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 73/ 100
Competitive context
59 Active assets in the Rhabdomyosarcoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Irinotecan Eisai Inc. | Phase 2 | BBB |
Ipilimumab Children's National Research Institute | Phase 2 | BB |
Irinotecan Milton S. Hershey Medical Center | Phase 2 | BB |
CALCIUM PHOSPHATE Children's Oncology Group | Phase 3 | BB |
Eloxatin National Cancer Institute (NCI) | Phase 2 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →